<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent profile studies of microRNA (miRNA) expression have documented a deregulation of miRNA (miR-320a) in human colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>However, its expression pattern and underlying mechanisms in the development and progression of colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> has not been elucidated clearly </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we performed real-time PCR to examine the expression levels of miR-320a in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues </plain></SENT>
<SENT sid="3" pm="."><plain>And then, we investigated its biological functions in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells by a gain of functional strategy </plain></SENT>
<SENT sid="4" pm="."><plain>Further more, by the combinational approaches of bioinformatics and experimental validation, we confirmed target associations of miR-320a in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Our results showed that miR-320a was frequently downregulated in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell lines and <z:hpo ids='HP_0003003'>colon cancer</z:hpo> tissues </plain></SENT>
<SENT sid="6" pm="."><plain>And we demonstrated that miR-320a restoration inhibited <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell proliferation and β-catenin, a functionally oncogenic molecule was a direct target gene of miR-320a </plain></SENT>
<SENT sid="7" pm="."><plain>Finally, the data of real-time PCR showed the reciprocal relationship between miR-320a and β-catenin's downstream genes in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> tissues </plain></SENT>
<SENT sid="8" pm="."><plain>These findings indicate that miR-320a suppresses the growth of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells by directly targeting β-catenin, suggesting its application in prognosis prediction and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> treatment </plain></SENT>
</text></document>